It is plausible that GLP‐1 RA also reduce the incidence of obesity‐associated cancers, as recently suggested by an observational study21; on the other hand, another investigation failed to detect any effect of these drugs on the incidence of cancer.22 The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.